Literature DB >> 24713187

Unexpected disappearance of portal cavernoma on long-term anticoagulation.

Gilberto Silva-Junior1, Fanny Turon2, Virginia Hernandez-Gea2, Anna Darnell3, Ángeles García-Criado3, Juan Carlos García-Pagán4.   

Abstract

Idiopathic non-cirrhotic portal hypertension is a rare disease of unknown etiology. Patients with idiopathic non-cirrhotic portal hypertension have an increased risk of developing portal vein thrombosis and this is especially prevalent when HIV is also present. We describe a unique case of a patient with idiopathic non-cirrhotic portal hypertension associated to HIV, who developed acute portal vein thrombosis that despite anticoagulation transformed in portal cavernoma and disappeared completely after five years of follow-up on continuous anticoagulation.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cavernomatosis portal; HIV; Idiopathic non-cirrhotic portal hypertension; Portal vein thrombosis

Mesh:

Substances:

Year:  2014        PMID: 24713187     DOI: 10.1016/j.jhep.2014.04.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  4 in total

1.  Pylephlebitis as a Complication of Cholangitis and Sepsis in an HIV-Positive Patient.

Authors:  Enrico Maria Zardi; Chiara Giorgi; Domenico Maria Zardi
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

Review 2.  Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis.

Authors:  Huan Chen; Jiaming Lei; Sicheng Liang; Gang Luo; Mingming Deng; Muhan Lü
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-21

3.  Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?

Authors:  Raffaele Licinio; Mariabeatrice Principi; Giuseppe Losurdo; Nicola Maurizio Castellaneta; Enzo Ierardi; Alfredo Di Leo
Journal:  ScientificWorldJournal       Date:  2014-12-29

Review 4.  Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein.

Authors:  Bo Wei; Zhiyin Huang; Chengwei Tang
Journal:  Front Med (Lausanne)       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.